Replimune stock (ticker: REPL) cratered on Tuesday after the biotech said the U.S. Food and Drug Administration rejected an ...

History, it has been said, is written by the winners. President Donald Trump is working that lever of power again. This time, ...

Rich's Ice Cream is recalling 110,292 cases of frozen dessert products across 23 states due to potential listeria ...

The debate over whether to use hormone therapy to treat menopausal women continues, as a Food and Drug Administration (FDA) expert panel weighs in. The panel, consisting […] ...

Sarepta Therapeutics is pausing shipments of its gene therapy for muscular dystrophy following several patient deaths that ...

Replimune Group, Inc. faces FDA setbacks with RP1, raising financial risks and dilution concerns. Click here to find out why I rate REPL stock a Sell.